Olfactory Training in Chronic Rhinosinusitis
NCT03055572 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2019-05-30
Summary
Persons with a loss of sense of smell, who agree to participate in this study, will be assigned to one of three groups: two groups will have smell training and the third group will not do smell training. Participants assigned to one of the smell training groups will be asked to smell four different odors in rotation for five minutes two times per day, a total of 10 minutes of participation per day, for 12 weeks. One smell training group will be given odors made of fragrance oils to use for smell training. The other smell training group will be given odors made of essential oils to use. Participants in all groups will continue taking all medications and nasal rinses for sinusitis as prescribed by their doctor.
Conditions
- Olfactory Dysfunction
Interventions
- OTHER
-
Olfactory Training with Essential Oils
Participants will be instructed to sniff one of four provided odors for approximately 10 seconds followed by a 10 second break before repeating with each successive odor for a total of 5 minutes. Essential oils will be used for the odors. The intervention will be completed in the morning before breakfast and in the evening before bed. Participants will document compliance by completing a log of olfactory training sessions.
- OTHER
-
Olfactory Training with Pure Fragrance Oils
Participants will be instructed to sniff one of four provided odors for approximately 10 seconds followed by a 10 second break before repeating with each successive odor for a total of 5 minutes. Pure fragrance oils will be used for the odors. The intervention will be completed in the morning before breakfast and in the evening before bed. Participants will document compliance by completing a log of olfactory training sessions.
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Thomas Edwards, MD · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2019-12-15
- Completion
- 2019-12-15
More Related Trials
-
Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19
NCT05384561 ·Status: RECRUITING ·Phase: NA
-
Olfactory Dysfunction of Rhinosinusitis - Cyclic Adenosine Monophosphate (cAMP)/Calcium Signaling Study
NCT00970190 ·Status: COMPLETED
-
Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)
NCT07190911 ·Status: COMPLETED ·Phase: NA
-
Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery
NCT06776042 ·Status: RECRUITING ·Phase: NA
-
Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps
NCT04104594 ·Status: TERMINATED ·Phase: NA
-
Olfactory Dysfunction of Rhinosinusitis
NCT00797004 ·Status: COMPLETED
-
Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19
NCT05133596 ·Status: COMPLETED ·Phase: NA
-
Acupuncture Therapy for COVID-Related Olfactory Loss
NCT04952389 ·Status: COMPLETED ·Phase: NA
-
Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
NCT04374474 ·Status: WITHDRAWN ·Phase: PHASE4
-
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
NCT06892704 ·Status: RECRUITING
-
Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants
NCT00610779 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
NCT05542095 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
NCT04964414 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
NCT06204432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Smell Changes & Efficacy of Nasal Theophylline
NCT03990766 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Single-center Cohort Study of Surgical Treatment of Chronic Rhinosinusitis
NCT06010316 ·Status: RECRUITING
-
Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage
NCT00292851 ·Status: COMPLETED
-
Coronavirus Smell Therapy for Anosmia Recovery
NCT04422275 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Structural and Microenvironmental Abnormalities in Olfactory Cleft on Olfaction in CRS
NCT06834477 ·Status: NOT_YET_RECRUITING
-
Use of Budesonide Diluted to Maximum Clinical Treatment of Patients With Chronic Rhinosinusitis With Polyoposis.
NCT05541419 ·Status: UNKNOWN ·Phase: NA
-
Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates
NCT03519061 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Medical Therapy Versus Sinus Surgery for Chronic Rhinosinusitis: A Prospective, Multi-institutional Study
NCT01255566 ·Status: COMPLETED
-
Mechanisms of Smell Improvement With Dupilumab.
NCT05964465 ·Status: COMPLETED ·Phase: PHASE4
-
Anosmia and Covid-19
NCT05246059 ·Status: COMPLETED ·Phase: NA
-
NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP
NCT03963648 ·Status: UNKNOWN ·Phase: NA